GLP1R and stroke disorder: Experimental animal studies have also shown that acute treatment with GLP-1 analogues and dipeptidyl peptidase-4 (DPP-4) inhibitors after a stroke is neuroprotective including better recovery [12, 35, 36], as recently reviewed [37–39].